151583-29-8

Basic information

• Product Name: methyl 3-(3-bromophenyl)propanoate
• Synonyms: methyl 3-(3-bromophenyl)propanoate;Methyl 3-(3-bromophenyl)propionate;ethyl 3-(3-broMophenyl)propanoate;Benzenepropanoic acid, 3-broMo-, Methyl ester;3-(3-Bromophenyl)propionic acid methyl ester;3-bromoBenzenepropanoic acid methyl ester
• CAS NO: 151583-29-8
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Mol File: 151583-29-8.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 287.3±15.0 °C(Predicted)
• Flash Point: >110℃
• Appearance: /
• Density: 1.382
• Refractive Index: 1.540
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: methyl 3-(3-bromophenyl)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-(3-bromophenyl)propanoate(151583-29-8)
• EPA Substance Registry System: methyl 3-(3-bromophenyl)propanoate(151583-29-8)

Safety Data

• WGK Germany: nwg
• Hazardous Substances Data: 151583-29-8(Hazardous Substances Data)

Usage

General Description

"Methyl 3-(3-bromophenyl)propanoate" is an organic compound that belongs to the ester chemical class. It is also known as methyl (3-bromophenyl)propanoate. This chemical is characterized by a methyl group attached to the carbon of a 3-(3-bromophenyl)propanoate group, which consists of a 3-carbon chain with a bromine-substituted phenyl ring attached. It is commonly used in the pharmaceutical and agrochemical industries as a building block in the synthesis of various compounds. It can also be used in the production of fragrances and as a flavoring agent in the food industry. Overall, "methyl 3-(3-bromophenyl)propanoate" is a versatile compound with a wide range of applications in various industries.

Upstream product

• 79432-87-4 methyl m-bromocinnamate 
• 67-56-1 methanol 
• 23689-33-0 3-bromophenyl propionic acid 
• 591-18-4 1-Bromo-3-iodobenzene 
• 3132-99-8 m-bromobenzoic aldehyde 
• 96-32-2 bromoacetic acid methyl ester 
• 14473-91-7 3-bromocinnamic acid 
• 42287-90-1 3-(3-bromophenyl)propanoic acid 
• 3650-77-9 methyl 3-(3'-bromophenyl)-acrylate 

Downstream Products

• 878158-09-9 trans-methyl 3-(3'-{2''-[3'''-(2''''-tert-butoxycarbonylaminoethyl)phenyl]vinyl}phenyl)-propionate 
• 1358694-03-7 1-(4-fluorobenzyl)-4-((3',5'-dimethoxybiphenyl-3-yl)methyl)-1H-imidazol-2-amine 
• 1358694-04-8 1-(3,5-difluorobenzyl)-4-((3',5'-dimethoxybiphenyl-3-yl)methyl)-1H-imidazol-2-amine 
• 153732-25-3 [2-(3-bromophenyl)ethyl]carbamic acid tert-butyl ester 
• 878158-08-8 [2-(3'-vinyl-phenyl)-ethyl]-carbamic acid tert-butyl ester 
• 878158-10-2 (E)-1-(3-(2-aminoethyl)phenyl)-2-(O-methyl hydrocinnam-3’-yl)-ethene 
• 878158-11-3 methyl trans-3-{3-[2-[3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]phenyl]vinyl]phenyl}propionate 
• 878158-12-4 trans-3-{3-[2-[3-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]phenyl]vinyl]phenyl}propionic acid 
• 42287-90-1 3-(3-bromophenyl)propanoic acid 
• 917024-58-9 methyl 3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate 
• 210115-30-3 3-(3-bromophenyl)propanal 

Relevant articles and documents

Manganese-catalyzed homogeneous hydrogenation of ketones and conjugate reduction of α,β-unsaturated carboxylic acid derivatives: A chemoselective, robust, and phosphine-free in situ-protocol

We communicate a user-friendly and glove-box-free catalytic protocol for the manganese-catalyzed hydrogenation of ketones and conjugated C[dbnd]C[sbnd]bonds of esters and nitriles. The respective catalyst is readily assembled in situ from the privileged [Mn(CO)5Br] precursor and cheap 2-picolylamine. The catalytic transformations were performed in the presence of t-BuOK whereby the corresponding hydrogenation products were obtained in good to excellent yields. The described system offers a brisk and atom-efficient access to both secondary alcohols and saturated esters avoiding the use of oxygen-sensitive and expensive phosphine-based ligands.

NEW FYN AND VEGFR2 KINASE INHIBITORS

The invention relates to a N-phenylcarbamoyl compound of Formula (I) or a pharmaceutically acceptable salt thereof for use in the inhibition of at least one of tyrosine kinase selected from Fyn and VEGFR2 in the treatment of diseases and disorders involved with one or both kinases. (Formula)

Dihydropyridine compound and application thereof to drugs

The invention relates to a dihydropyridine compound and application of the dihydropyridine compound serving as a drug, in particular to application of the dihydropyridine compound serving as a drug for treating and preventing hepatitis B. Specifically, the invention relates to the compound shown as the general formula (I) or (Ia) (please see the specifications for the general formula (I) or (Ia))or stereoisomers, tautomer, a nitrogen oxide, solvate, metabolites and medically acceptable salt of the compound or a prodrug of the compound, wherein all variables are defined in the specification. The invention further relates to application of the compound shown as the general formula (I) or (Ia) or enantiomers, non-enantiomers, the tautomer, hydrates, the solvate or the medically acceptable salt of the compound serving as drugs, in particular to application of the compound or the enantiomers, the non-enantiomers, the tautomer, the hydrates, the solvate or the medically acceptable salt of the compound serving as the drugs for treating and preventing hepatitis B.